Mao YQ - Search Results

1

Bone Marrow Mesenchymal Stem Cell-Derived Exosomes Improves Spinal Cord Function After Injury in Rats by Activating Autophagy.

Gu J, Jin ZS, Wang CM, Yan XF, Mao YQ, Chen S. Gu J, et al. Among authors: mao yq. Drug Des Devel Ther. 2020 Apr 29;14:1621-1631. doi: 10.2147/DDDT.S237502. eCollection 2020. Drug Des Devel Ther. 2020. PMID: 32425507 Free PMC article.

2

Ubiquitin-proteasome system-mediated ubiquitination modification patterns and characterization of tumor microenvironment infiltration, stemness and cellular senescence in low-grade glioma.

Gu J, Pang L, Yan D, Wang C, Song Y, Jin Z, Xu Z, Mao Y, Liu S, Chen S. Gu J, et al. Aging (Albany NY). 2023 Apr 11;15(8):2970-2998. doi: 10.18632/aging.204650. Epub 2023 Apr 11. Aging (Albany NY). 2023. PMID: 37053008 Free PMC article.

3

FLOT1 promotes tumor development, induces epithelial-mesenchymal transition, and modulates the cell cycle by regulating the Erk/Akt signaling pathway in lung adenocarcinoma.

Zhang L, Mao Y, Mao Q, Fan W, Xu L, Chen Y, Xu L, Wang J. Zhang L, et al. Thorac Cancer. 2019 Apr;10(4):909-917. doi: 10.1111/1759-7714.13027. Epub 2019 Mar 5. Thorac Cancer. 2019. PMID: 30838797 Free PMC article.

4

MAGEC2 Correlates With Unfavorable Prognosis And Promotes Tumor Development In HCC Via Epithelial-Mesenchymal Transition.

Gu X, Mao Y, Shi C, Ye W, Hou N, Xu L, Chen Y, Zhao W. Gu X, et al. Onco Targets Ther. 2019 Sep 24;12:7843-7855. doi: 10.2147/OTT.S213164. eCollection 2019. Onco Targets Ther. 2019. PMID: 31576142 Free PMC article.

5

CD137 Co-Stimulation Improves The Antitumor Effect Of LMP1-Specific Chimeric Antigen Receptor T Cells In Vitro And In Vivo.

Tang X, Tang Q, Mao Y, Huang X, Jia L, Zhu J, Feng Z. Tang X, et al. Onco Targets Ther. 2019 Nov 7;12:9341-9350. doi: 10.2147/OTT.S221040. eCollection 2019. Onco Targets Ther. 2019. PMID: 31807014 Free PMC article.

6

Macrophages promote growth, migration and epithelial-mesenchymal transition of renal cell carcinoma by regulating GSDMD/IL-1β axis.

Xie D, Mao Y, Du N, Ji H, Li J. Xie D, et al. Cytokine. 2022 Nov;159:156021. doi: 10.1016/j.cyto.2022.156021. Epub 2022 Aug 31. Cytokine. 2022. PMID: 36057231

7

A novel human Fab antibody for Trop2 inhibits breast cancer growth in vitro and in vivo.

Lin H, Zhang H, Wang J, Lu M, Zheng F, Wang C, Tang X, Xu N, Chen R, Zhang D, Zhao P, Zhu J, Mao Y, Feng Z. Lin H, et al. Int J Cancer. 2014 Mar 1;134(5):1239-49. doi: 10.1002/ijc.28451. Epub 2013 Sep 19. Int J Cancer. 2014. PMID: 23982827

8

A novel immune checkpoint siglec-15 antibody inhibits LUAD by modulating mφ polarization in TME.

Xiao X, Peng Y, Wang Z, Zhang L, Yang T, Sun Y, Chen Y, Zhang W, Chang X, Huang W, Tian S, Feng Z, Xinhua N, Tang Q, Mao Y. Xiao X, et al. Pharmacol Res. 2022 Jul;181:106269. doi: 10.1016/j.phrs.2022.106269. Epub 2022 May 20. Pharmacol Res. 2022. PMID: 35605813

9

COPB2 promotes cell proliferation and tumorigenesis through up-regulating YAP1 expression in lung adenocarcinoma cells.

Pu X, Wang J, Li W, Fan W, Wang L, Mao Y, Yang S, Liu S, Xu J, Lv Z, Xu L, Shu Y. Pu X, et al. Biomed Pharmacother. 2018 Jul;103:373-380. doi: 10.1016/j.biopha.2018.04.006. Epub 2018 Apr 24. Biomed Pharmacother. 2018. PMID: 29674272

10

ROR1 associates unfavorable prognosis and promotes lymphoma growth in DLBCL by affecting PI3K/Akt/mTOR signaling pathway.

Mao Y, Xu L, Wang J, Zhang L, Hou N, Xu J, Wang L, Yang S, Chen Y, Xiong L, Zhu J, Fan W, Xu J. Mao Y, et al. Biofactors. 2019 May;45(3):416-426. doi: 10.1002/biof.1498. Epub 2019 Feb 24. Biofactors. 2019. PMID: 30801854

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

209 results

Search Page

Filters